Youthful Pep Talk: Expert Conversations on Peptide Science

Why we built a place where clinicians can disagree in public, show their evidence, and help patients tell opinion from proof.

A popular clinician tier list ranks peptides from S to D. We put each ranking next to our evidence grade to show where experience and published data agree, and where they part ways.

Physicians, pharmacists and researchers: join a Pep Talk or write a Perspective. Here is how we work.

Triple agonists, liver fat, muscle preservation and what the newest phase 3 trials really show.

Why repair peptides are so popular, why the human evidence is thin, and what a good trial would look like.

Secretagogues versus growth hormone, IGF-1 monitoring, and the safety questions that still need answers.

Can peptides that target the mitochondria or telomeres change how we age? A look at the science so far.

Nasal neuropeptides, sleep, anxiety and memory: separating promising signals from wishful thinking.

How hypothalamic and pituitary signals drive fertility and libido, and where peptides fit in modern care.

A rheumatologist's view on immune-modulating peptides, autoimmunity and the evidence we still need.